PATENT CLAIM ANALYSIS

Application Number: 15983282
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject having reduced kidney function.

Claim (Index 152):
A method of increasing or improving long-term renal function and treating a cardiovascular-related disease in a subject having diabetes, the method comprising administering to the subject a composition comprising about 4 g of ethyl eicosapentaenoate (E-EPA) per day.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15411500', '14496429', '13403699', '15886422', '15422634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.598048024377447
- 35 USC 102 Novelty (BERT): 0.5011296786350864
- Combined Prediction Score: 0.5883561898032109
- Mean Citation Score: 283.324164
- Max Citation Score: 290.16418
- Similarity Product: 213.81405493551253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test